Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer
Clinical trial NCT01861197 · UNKNOWN
Trial details
- NCT number
- NCT01861197
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2015-01-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.